$55.14
4.21% yesterday
Nasdaq, Nov 25, 10:00 pm CET
ISIN
US30063P1057
Symbol
EXAS
Sector
Industry

Exact Sciences Corporation Stock price

$55.14
-13.97 20.21% 1M
+5.30 10.63% 6M
-18.84 25.47% YTD
-10.68 16.23% 1Y
-32.95 37.40% 3Y
-26.58 32.53% 5Y
+30.24 121.45% 10Y
Nasdaq, Closing price Mon, Nov 25 2024
+2.23 4.21%
ISIN
US30063P1057
Symbol
EXAS
Sector
Industry

Key metrics

Market capitalization $10.21b
Enterprise Value $11.97b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 121.56
EV/Sales (TTM) EV/Sales 4.44
P/S ratio (TTM) P/S ratio 3.79
P/B ratio (TTM) P/B ratio 3.18
Revenue growth (TTM) Revenue growth 11.91%
Revenue (TTM) Revenue $2.69b
EBIT (operating result TTM) EBIT $-237.84m
Free Cash Flow (TTM) Free Cash Flow $98.43m
Cash position $1.02b
EPS (TTM) EPS $-1.17
P/E forward negative
P/S forward 3.72
EV/Sales forward 4.37
Short interest 7.67%
Show more

Is Exact Sciences Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Exact Sciences Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

23 Analysts have issued a Exact Sciences Corporation forecast:

19x Buy
83%
4x Hold
17%

Analyst Opinions

23 Analysts have issued a Exact Sciences Corporation forecast:

Buy
83%
Hold
17%

Financial data from Exact Sciences Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
2,692 2,692
12% 12%
100%
- Direct Costs 822 822
14% 14%
31%
1,870 1,870
11% 11%
69%
- Selling and Administrative Expenses 1,446 1,446
4% 4%
54%
- Research and Development Expense 447 447
10% 10%
17%
-22 -22
81% 81%
-1%
- Depreciation and Amortization 216 216
5% 5%
8%
EBIT (Operating Income) EBIT -238 -238
30% 30%
-9%
Net Profit -214 -214
24% 24%
-8%

In millions USD.

Don't miss a Thing! We will send you all news about Exact Sciences Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Exact Sciences Corporation Stock News

Neutral
Business Wire
about 2 hours ago
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conferences and invited investors to participate by webcast. Citi Global Healthcare Conference, Miami Fireside chat on Tuesday, December 3, 2024 at 8:45 a.m. ET Evercore HealthCONx Conference, ...
Neutral
Business Wire
about 14 hours ago
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, will present 10 abstracts demonstrating the breadth of its Precision Oncology portfolio at the 2024 annual San Antonio Breast Cancer Symposium® (SABCS®) from December 10-13 in San Antonio, Texas. “Exact Sciences is committed to improving breast cancer care by providi...
Neutral
Seeking Alpha
7 days ago
Exact Sciences Corporation (NASDAQ:EXAS ) Jefferies London Healthcare Conference November 19, 2024 6:00 AM ET Company Participants Kevin Conroy - Chairman and CEO Aaron Bloomer - Chief Financial Officer Conference Call Participants Tycho Peterson - Jefferies Tycho Peterson Thank you both. Kevin, while you're walking up to the podium there, maybe you can talk a little bit about your recent purch...
More Exact Sciences Corporation News

Company Profile

EXACT Sciences Corp. is a molecular diagnostics company, which focuses on the early detection and prevention of colorectal cancer. It developed Cologuard, a screening test for the early detection of colorectal cancer and pre-cancer. The company was founded on February 10, 1995 and is headquartered in Madison, WI.

Head office United States
CEO Kevin Conroy
Employees 6,600
Founded 1995
Website www.exactsciences.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today